Infinity Pharmaceuticals, Inc.
(NASDAQ : INFI)

( )
INFI PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
BIIBBiogen Inc.
1.31%353.031.2%$871.11m
AMGNAmgen Inc.
-0.53%194.881.2%$564.77m
CELGCelgene Corporation
-0.54%85.231.2%$555.79m
GILDGilead Sciences, Inc.
-0.16%77.260.9%$499.41m
SRPTSarepta Therapeutics, Inc.
-1.97%136.6816.6%$376.94m
VRTXVertex Pharmaceuticals Incorporated
0.40%181.221.9%$331.68m
REGNRegeneron Pharmaceuticals, Inc.
-0.79%364.752.6%$305.25m
ILMNIllumina, Inc.
-1.63%301.993.5%$267.19m
BLUEBluebird Bio, Inc.
-1.83%177.3015.7%$219.07m
NKTRNektar Therapeutics
0.00%47.795.6%$188.00m
ALXNAlexion Pharmaceuticals, Inc.
-0.95%134.582.0%$175.68m
FMIFoundation Medicine, Inc.
0.00%136.708.8%$168.36m
EXASExact Sciences Corporation
1.41%64.6625.4%$159.06m
BMRNBioMarin Pharmaceutical Inc.
-0.85%102.734.4%$138.72m
EXELExelixis, Inc.
-3.61%21.076.4%$137.74m

Company Profile

Infinity Pharmaceuticals, Inc. operates as a biopharmaceutical company, which engages in discovering, developing and delivering medicines for people with cancer. The company was founded by Steven H. Holtzman on March 22, 1995 and is headquartered in Cambridge, MA.